首页>Cancer biology & therapy>In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player
In human retinoblastoma Y79 cells okadaic acid-parthenolide co-treatment induces synergistic apoptotic effects, with PTEN as a key player
作者单位:Institute of Biomedicine and Molecular Immunology Alberto Monroy, National Research Council (CNR),[1]Laboratory of Biochemistry, Department of Experimental Biomedicine and Clinical Neurosciences[2]Laboratory of Biochemistry, Department of Biological, Chemical and Pharmaceutical Sciences and[3]Institute for Cancer Research and Molecular Medicine, College of Science and Biotechnology, Temple[4]